image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Chemring - Supplier of countermeasures growing on back of US military spend

February 2006

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • CHG
  • Price:
  • 314p
measures for protecting military assets from missile attacks, has been a major beneficiary of the recent conflicts in Iraq and Afghanistan. Indeed, news of a memorandum of understanding (MoU) with the US Department of Defence, expected to be worth at least US$150m (£85m) over the next three years, saw the shares spike up over 200p to an all-time high of 925p. Chemring’s countermeasures division has fashioned the happy knack of being very much in the right place at the right time when it comes to milking government defence budgets. Aside from a traumatic fire in 2001, which temporarily disrupted production at a key facility in the US, this business has posted exceptional and consistent growth each year, with turn ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMTED TIME OFFER

SUBSCRIBE TODAY AND SAVE £30 USING OFFER CODE 30OFFTMI

To access our archive of articles and receive current issues you need to subscribe